Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

I did not see the FDA asking for more data/testing on toxic vaccines.

https://rumble.com/vk23ha-patient-asserts-sudden-neurological-disorder-caused-by-covid-vaccine.html

RLF-100/AVIPTADIL may help the afflicted with a neurological disorder after a toxic jab(s)

In the central and peripheral nervous system, vasoactive intestinal peptide (VIP), a 28-amino acid neuropeptide, is released to support neuronal survival in both physiological and pathological condition. VIP can inhibit the neurodegeneration induced by the loss of neurons.

https://pubmed.ncbi.nlm.nih.gov/27786097/

There is mounting evidence that VIP expression and signaling is altered in numerous neurological disorders, and it is becoming apparent that VIP and its receptors could be therapeutic loci for the treatment of several pathological conditions of the central nervous system. In this review, we describe the pathology of several major neurological disorders and discuss the potential pharmacotherapeutic role of VIP and its receptors for the treatment of disorders such as Alzheimers disease, Parkinsons disease, and Autism Spectrum Disorders.

https://www.eurekaselect.com/node/94030/article/-therapeutic-potential-of-vasoactive-intestinal-peptide-and-its-receptors-in-neurological-disorders